Streetbeat News

Stock Prices

ZVRA

Zevra Therapeutics, a company focused on rare disease therapeutics, announced its participation in upcoming investor conferences in February. This could increase visibility and investor interest in the company.

Portfolio Pulse from

January 29, 2025 | 9:15 pm

MLAC

Mountain Lake Acquisition Corp. (NASDAQ: MLAC) announced that starting February 3, 2025, investors can separately trade its Class A ordinary shares and rights on Nasdaq. This follows the company's IPO on December 16, 2024.

Portfolio Pulse from

January 29, 2025 | 9:15 pm

MU

Kessler Topaz Meltzer & Check, LLP has filed a securities class action lawsuit against Micron Technology, Inc. (MU) for investors who acquired stock between September 28, 2023, and December 18, 2024. The lead plaintiff deadline is March 10, 2025.

Portfolio Pulse from

January 29, 2025 | 9:15 pm

NVDA

NVIDIA's stock price was negatively impacted by concerns over DeepSeek's competition, but this is seen as an exaggerated threat, presenting a buying opportunity.

Portfolio Pulse from

January 29, 2025 | 9:15 pm

CP

Canadian Pacific Kansas City (CPKC) reported strong fourth-quarter results with a 3% revenue increase to $3.9 billion and a 9% rise in core adjusted EPS to $1.29. The company also improved its operating ratio and safety metrics, positioning itself for growth in 2025.

Portfolio Pulse from

January 29, 2025 | 9:15 pm

FTAI

A class action lawsuit has been filed against FTAI Aviation Ltd. (NASDAQ:FTAI) with a deadline of March 18, 2025, for investors to join. The lawsuit pertains to potential recovery under federal securities laws.

Portfolio Pulse from

January 29, 2025 | 9:15 pm

SLNO

Soleno Therapeutics, a clinical-stage biopharmaceutical company, will participate in investor conferences in February. This could increase visibility and investor interest in the company.

Portfolio Pulse from

January 29, 2025 | 9:15 pm

STGW

Assembly, a Stagwell agency, has launched STAGE AI, an AI-powered evolution of its STAGE operating system, enhancing efficiency and business impact.

Portfolio Pulse from

January 29, 2025 | 9:15 pm

IVA

Inventiva published results from a clinical trial showing that lanifibranor significantly improves insulin resistance in patients with T2D and MASLD. The study was published in the Journal of Hepatology.

Portfolio Pulse from

January 29, 2025 | 9:15 pm

FBIN

Fortune Brands Innovations, Inc. (NYSE: FBIN) has been named to The Wall Street Journal's Top 250 Best-Managed Companies List of 2024, highlighting its industry-leading innovation and management excellence.

Portfolio Pulse from

January 29, 2025 | 9:15 pm